| CTRI Number |
CTRI/2025/11/097863 [Registered on: 21/11/2025] Trial Registered Prospectively |
| Last Modified On: |
17/11/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Explaining the Function of Mitochondria for Understanding the Basis of Ayurvedic Prakriti |
|
Scientific Title of Study
|
Elucidating Mitochondrial Function by Profiling of Mito-nuclear Gene Variations towards Understanding the Molecular Basis of Ayurvedic Prakriti: A Determinant of Health and Longevity |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Remya E |
| Designation |
Research Officer (Ayurveda) |
| Affiliation |
CCRAS |
| Address |
Central Ayurveda Research Institute, Kalinga Studio Chowk, Bharatpur, Bhubaneswar, Odisha Harinilayam, Elavana, Eranhikkal, elathur, Kozhikode - 673303, Kerala Khordha ORISSA 751029 India |
| Phone |
9447378133 |
| Fax |
|
| Email |
drremyaenair@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Remya E |
| Designation |
Research Officer (Ayurveda) |
| Affiliation |
CCRAS |
| Address |
Central Ayurveda Research Institute, Kalinga Studio Chowk, Bharatpur, Bhubaneswar, Odisha Harinilayam, Elavana, Eranhikkal, elathur, Kozhikode - 673303, Kerala
ORISSA 751029 India |
| Phone |
9447378133 |
| Fax |
|
| Email |
drremyaenair@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Remya E |
| Designation |
Research Officer (Ayurveda) |
| Affiliation |
CCRAS |
| Address |
Central Ayurveda Research Institute, Kalinga Studio Chowk, Bharatpur, Bhubaneswar, Odisha Harinilayam, Elavana, Eranhikkal, elathur, Kozhikode - 673303, Kerala
ORISSA 751029 India |
| Phone |
9447378133 |
| Fax |
|
| Email |
drremyaenair@gmail.com |
|
|
Source of Monetary or Material Support
|
| Central Council for Research in Ayurvedic Sciences |
|
|
Primary Sponsor
|
| Name |
Central Council for Research in Ayurvedic Sciences |
| Address |
Central Council for Research in Ayurvedic Sciences, 61-65, opp. D’ Block, D Block, Janakpuri Institutional Area, Janakpuri, New Delhi, Delhi 110058 |
| Type of Sponsor |
Research institution |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 2 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Remya E |
Central Ayurveda Research institute , Bhubaneswar |
Central Ayurveda Research institute , Near Kalinga Studio Chowk, Bharatpur, Bhubaneswar Khordha ORISSA |
9447378133
drremyaenair@gmail.com |
| Dr Subhash Singh |
ICMR - Regional Medical Research Centre, Bhubaneswar |
ICMR- Regional Medical Research Centre, Chandrasekharpur
Bhubaneswar- 751023, Odisha, India Khordha ORISSA |
9419125539
subhash0974@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Healthy Human Volunteers |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details |
|
| Intervention |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
25.00 Year(s) |
| Gender |
Both |
| Details |
1. Apparently Healthy gender and age matched participants of age between 18-25 years of Prakriti subtypes.
2. Apparently healthy parents of participants who are willing to participate in the study providing a writtern consent
3. Participant native of the geographical zone.
|
|
| ExclusionCriteria |
| Details |
1. Participants suffering from any acute or chronic disease condition.
2. Participant on any medication or health supplement.
3. Mentally challenged participants.
4. Not willing to provide written informed consent and participate in the study
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| SNP signatures of the mito-nuclear genetic components of the ETC complexes for the different Prakriti subtypes. |
Baseline |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. Insight into the inheritance of the parental traits (SNPs) within the mito-nuclear genetic components of the ETC complexes in determining the Prakriti of the offspring.
2. Any co-relation with SNP signatures of the mito-nuclear genetic components of the ETC complexes with the Agni status of the study subjects.
3. Any co-relation with Prakriti subtypes of the study subjects with other clinical and biochemical parameters analyzed such as levels of stress, anxiety, blood plasma total antioxidant levels, and other blood plasma analytes.
|
Baseline |
|
|
Target Sample Size
|
Total Sample Size="605" Sample Size from India="605"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/12/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Upon approval from the Institutional Ethics Committee screening for healthy individuals, in the age agroup 18-25 will be done in the OPD of CARI, Bhubaneswar, extensive camps in various educational institutions in Bhubaneswar and various NGOs.The SRF and investigators will be engaged in the process of screening and prakriti assessment of the apparently healthy individuals. Gender and age matched 605 apparently healthy participants (participants and a subset of study participants’ biological parents of the participants which will be equally and randomly selected as per feasibility of the study) satisfying the inclusion criteria who will voluntarily give written informed consent for the study would be enrolled as volunteers for participating in this study. The participant will be screened for prakriti using CCRAS AYUR Prakriti assessment web portal. The swasthya assessment will be done using the CCRAS Swasthya Assessment tool. The Agni assessment of the enrolled participant will be done through Agni assessment tool developed by CCRAS. The participants will be subjected to further screening using laboratory investigations (at ICMR-RMRCBB). The participants found as having excellent health as per SAS will be enrolled in study. Detailed demographic, personal including familial & habitual traits, and medical and treatment history of the participants will be recorded in a specific proforma developed incorporating Ayurveda details as well for the study. The dietry recall of the participant will be done prior to sample collection. The perceived stress will be assessed using Perceived Stress Scale and anxiety level of participants will be assessed using the HAM-A scale and nutritional index measurement will be done on the day of sample collection.
Briefly, 3-4 ml peripheral blood would be collected from the forearm using heparin containing vacutainer tubes. The blood samples will be transported to ICMR-RMRCBB haematological and biochemical evaluation. These blood samples will be used for biochemical analysis to determine the physiological health, and antioxidant of the study participant. Blood spots will be collected in FTA cards as per the SOP and the dried blood spots in FTA cards will be transported to ICMR-RMRCBB for genomic DNA isolation, as per standard procedures, for use in the sequencing of the mito-nuclear ETC exome. |